David Beauvais
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- CAR-T cell therapy research
Papers in
- Oncology 17
- CAR-T cell therapy research 14
- Hematology 12
- Hematopoietic Stem Cell Transplantation 5
- Acute Myeloid Leukemia Research 5
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Ibrahim Yakoub‐Agha (24 shared papers)Thierry Façon (3 shared papers)Pauline Varlet (3 shared papers)Jacques Trauet (1 shared paper)Julie Demaret (1 shared paper)Myriam Labalette (2 shared papers)Charles Herbaux (2 shared papers)Suman Mitra (3 shared papers)
- Journals
- Blood Advances (3 papers)Blood (3 papers)Bone Marrow Transplantation (2 papers)Clinical Cancer Research (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- FranceSwitzerlandGermany
In The Last Decade
David Beauvais
32 papers receiving 330 citations
Peers
Comparison fields: 5 of 57
- Hematology 93
- Oncology 158
- Genetics 41
- Immunology 38
- Occupational Therapy 6
Countries citing papers authored by David Beauvais
This map shows the geographic impact of David Beauvais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Beauvais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Beauvais more than expected).
Fields of papers citing papers by David Beauvais
This network shows the impact of papers produced by David Beauvais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Beauvais. The network helps show where David Beauvais may publish in the future.
Co-authors
The 25 scholars most cited alongside David Beauvais, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 45 | |
| 2 | 2014 | 43 | |
| 3 | Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. | 1997 | 32 |
| 4 | 2018 | 30 | |
| 5 | 2021 | 28 | |
| 6 | 2019 | 21 | |
| 7 | 2020 | 15 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 9 | |
| 10 | 2020 | 9 | |
| 11 | 2019 | 9 | |
| 12 | 2019 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2019 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2020 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2018 | 5 | |
| 20 | 2019 | 5 |
About David Beauvais
David Beauvais is a scholar working on Oncology, Hematology, Epidemiology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 40 papers that have together received 340 indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (5 papers), Cytomegalovirus and herpesvirus research (4 papers), Herpesvirus Infections and Treatments (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Hematology (93 citations), Oncology (158 citations), Genetics (41 citations), Immunology (38 citations) and Occupational Therapy (6 citations). David Beauvais has collaborated with scholars based in France, Switzerland and Germany. Frequent co-authors include Ibrahim Yakoub‐Agha, Thierry Façon, Pauline Varlet, Jacques Trauet, Julie Demaret, Myriam Labalette, Charles Herbaux, Suman Mitra, Timothy Campbell and Salomon Manier. Their work appears in journals such as Blood Advances, Blood, Bone Marrow Transplantation, Clinical Cancer Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.